Short Interest in Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN) Grows By 406.3%

Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN) was the target of a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 8,100 shares, an increase of 406.3% from the December 31st total of 1,600 shares. Based on an average trading volume of 356,600 shares, the short-interest ratio is currently 0.0 days.

Enzon Pharmaceuticals Price Performance

Shares of OTCMKTS:ENZN opened at $0.13 on Wednesday. The stock’s 50-day moving average is $0.13 and its 200 day moving average is $0.13. The company has a market cap of $9.51 million, a PE ratio of 13.75 and a beta of 0.27. Enzon Pharmaceuticals has a 1 year low of $0.06 and a 1 year high of $0.24.

About Enzon Pharmaceuticals

Enzon Pharmaceuticals, Inc, together with its subsidiaries, does not have significant operations. Previously, the company marketed its patented drug product, PegIntron. It also had a marketing agreement with Micromet AG relating to the Vicineum drug; and a licensing agreement regarding SC Oncaspar and certain other drugs.